Hangzhou, China

Wenshou Wang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Wenshou Wang: Innovator in Ionizable Lipid Compounds

Introduction

Wenshou Wang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of ionizable lipid compounds. His work has implications for the delivery of nucleic acids, which is crucial in various medical applications.

Latest Patents

Wang holds 1 patent for his innovative work on ionizable lipid compounds. The patent describes a class of compounds represented by formula (IV), including pharmaceutically acceptable salts, isotopic variants, tautomers, or stereoisomers. Additionally, it details a nanoparticle pharmaceutical composition that incorporates these compounds, emphasizing their application in nucleic acid delivery.

Career Highlights

Throughout his career, Wenshou Wang has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with Beijing Jitai Pharmaceutical Technology Co., Ltd. and Hangzhou Jitai Pharmaceutical Technology Co., Ltd. His expertise in lipid compounds has positioned him as a key player in the development of advanced pharmaceutical solutions.

Collaborations

Wang has collaborated with talented professionals in his field, including Lin Zhang and Liu Yang. These partnerships have contributed to the advancement of his research and the successful application of his inventions.

Conclusion

Wenshou Wang's contributions to the field of ionizable lipid compounds highlight his innovative spirit and dedication to pharmaceutical advancements. His work continues to influence the delivery of nucleic acids, showcasing the importance of his inventions in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…